health
FINGER trial analysis links Alzheimer’s blood markers to cognition
A secondary analysis of the two-year FINGER trial found that Alzheimer’s-related blood markers were associated with cognitive trajectories, but did not significantly modify the cognitive benefit of a multidomain lifestyle intervention. The findings come from a medRxiv preprint.